SOUTH SAN FRANCISCO, Calif., Aug. 27 diaDexus, Inc. todayannounced the appointment of Physicians Sales & Service, Inc. (PSS) asdistributors of the PLAC Test to physician office laboratories in the UnitedStates.
The PLAC Test is the only blood test cleared by the United States Food &Drug Administration (FDA) to assess risk for both coronary heart disease andischemic stroke associated with atherosclerosis. The PLAC Test provides newinformation, over and above traditional cardiovascular risk factors, to helpidentify individuals at increased risk of suffering a heart attack or stroke.The PLAC Test measures lipoprotein-associated phospholipase A2 (Lp-PLA2), avascular-specific inflammatory enzyme implicated in the formation ofrupture-prone plaque. It is plaque rupture and thrombosis, not stenosis, thatcause the majority of cardiac events.
According to Patrick Plewman, president and chief executive officer ofdiaDexus, the agreement is another important milestone for the company as itcontinues to expand the availability of the PLAC Test beyond the traditionallaboratory setting. "This new relationship with PSS and its outstanding salesforce enables more people to benefit from assessment of their risk for heartattack and stroke, events that can be prevented with appropriate lifestylemodification and therapeutic treatment," Plewman said.
"PSS is excited to offer this important, high-value diagnostic test to thephysician lab customers we serve," said John Sasen, PSS World Medical's chiefmarketing officer. "The addition of the PLAC Test to our offering demonstratesour commitment to providing cutting edge technology to help clinicians deliverhigh quality patient care in their office."
diaDexus, Inc., a privately held diagnostics company based in South SanFrancisco, is focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs incardiovascular disease. For more information, visit http://www.plactest.comor http://www.diaDexus.com.
Physician Sales & Service (PSS) is the physician business of PSS WorldMedical, Inc. (Nasdaq: PSSI), a national distributor of medical products tophysicians and elder care providers through its two business units. Since itsinception in 1983, PSS has become a leader in the two market segments that itserves with a focused market approach to customer services, a consultativesales force, strategic acquisitions, strong arrangements with productmanufacturers and a unique culture of performance.
SOURCE diaDexus, Inc.